Protein Barcoding: Multiplexed Screening for High-efficiency Pre-clinical Studies 

Accelerate decisions and reduce costs with 8× the analytical power 

Protein barcoding makes the pre-clinical drug development process more efficient and cost-effective through multiplexed protein screening, to accelerate the path to first in human trials.

This infographic highlights how multiplexing with Next-Gen Protein Sequencing™ and the Quantum-Si Barcoding Kit is a standout solution for pre-clinical researchers seeking a highly efficient solution.

Key takeaways from this infographic include:

• Direct protein detection: Quantify expression and differentiate functional performance of proteins 
• Multiplexing power: Test multiple candidates in a single model organism with 8× the power of single-plex analysis
• Cost-effectiveness: Enables faster, more accurate, and cost-effective nucleic acid therapeutic development by overcoming traditional bottlenecks in AAV delivery screening
• Analytical validity: Detect low-abundance proteins down to 50 fmol and differentiate expression changes across a tenfold dynamic range